trending Market Intelligence /marketintelligence/en/news-insights/trending/awggxlnpv6t5xu9n91ox2q2 content esgSubNav
In This List

Entera Bio appoints chairman

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Entera Bio appoints chairman

Entera Bio Ltd. named Gerald Lieberman as board chairman.

Lieberman was formerly the president and COO of AllianceBernstein LP, a privately owned investment manager, until 2009. Before that, he was with Sanford C. Bernstein & Co. Inc. as the senior vice president for finance and administration.

Israel-based Entera Bio develops and commercializes orally delivered treatments for orphan indications and other areas with significant unmet medical needs. The company is developing an oral formulation of the parathyroid hormone to treat hypoparathyroidism and osteoporosis.